{"name":"Wittgenbio","domain":"wittgenbio.com","url":"https://optimly.ai/brand/wittgenbio","is_claimed":false,"categories":["biotechnology","diagnostics-labs","healthcare-it"],"headers":[{"header":"Overview","sections":[{"key":"short_description","label":"Tagline","shape":"text","content":"Unrivaled precision using Single-cell GenAI to extract cellular-level biomarkers from archived bulk RNA or pathological image data, offering 7x higher precision in identifying responders, 95% cost savings over traditional single-cell profiling, and regulator-ready patient stratification at trial scale without the single-cell burden.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://wittgenbio.com","updated_at":"2026-10-04T00:03:48.466000+00:00"},{"key":"description","label":"Description","shape":"text","content":"Wittgenbio provides a Single-Cell GenAI powered Virtual Cell-to-Patient profiling technology to accelerate clinical success. Their platform transforms bulk RNA or pathological image data into regulator-ready patient stratification insights, de-risking clinical trials and enabling marker-driven therapeutic discovery.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://wittgenbio.com","updated_at":"2026-10-04T00:03:48.466000+00:00"}]},{"header":"Offerings","sections":[{"key":"core_capabilities","label":"Core capabilities","shape":"text","content":"Virtual Cell-to-Patient profiling technology\nLEIBER-X platform. These solutions provide single-cell clarity from bulk or image samples for patient stratification\nbiomarker discovery\nand clinical trial de-risking.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://wittgenbio.com","updated_at":"2026-10-04T00:03:48.466000+00:00"},{"key":"pricing","label":"Pricing","shape":"text","content":"Not explicitly mentioned, but implies a service or platform subscription model based on the value proposition of cost savings and accelerated research.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://wittgenbio.com","updated_at":"2026-10-04T00:03:48.466000+00:00"}]},{"header":"Audience","sections":[{"key":"target_industry","label":"Target industry","shape":"text","content":"Clinical leaders, pharmaceutical companies, and academic partners involved in therapeutic development and patient stratification.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://wittgenbio.com","updated_at":"2026-10-04T00:03:48.466000+00:00"}]}],"last_refreshed_at":"2026-10-04T00:03:48.466000+00:00","claim_url":"https://app.optimly.ai/sign-up?claim=wittgenbio"}